Delivery Order SPE2DB20D1109-SPE2DB24FN38S
- Not listed
- This federal contract award is for the delivery of MULTAQ 400 MG TABLET 60S pharmaceutical products to the Defense Logistics Agency (DLA), a defense agency. The prime contractor is Amerisourcebergen Drug Corp, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government. The contract has a ceiling value of $1,753.32 and is a firm fixed-price delivery order with an ultimate completion date of April 18, 2024. The contract is not designated as a set-aside....
- This federal contract award is for the delivery of MULTAQ 400 MG TABLET 60S pharmaceutical products to the Defense Logistics Agency (DLA), a defense agency. The award was made to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on May 23, 2025 with a ceiling value of $10,081.17. The contract has a performance period ending on May 27, 2025 and is a Firm Fixed Price Delivery Order, with no set-aside designation. Amerisourcebergen Drug Corp holds a significant $999,999,999.00...
- This federal contract award is for the delivery of MULTAQ 400 MG TABLET 60S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract has a ceiling value of $22,862.40 and is a Firm Fixed Price Delivery Order with a completion date of December 13, 2024. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that...
- This federal contract award is for the delivery of MULTAQ 400 MG TABLET 60S pharmaceutical products. The $3,207.06 firm fixed price contract was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on February 18, 2025. The contract has a ceiling value of $3,207.06 and an ultimate completion date of February 19, 2025. This contract is not associated with any set-aside designations. Amerisourcebergen Drug Corp is the prime contractor...
- This federal contract award is for the delivery of MULTAQ 400 MG TABLET 60S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $5,542.43 firm fixed price contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on January 30, 2023, with a completion date of January 31, 2023. The contract is a delivery order and is not designated as a set-aside. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award is for the delivery of MULTAQ 400 MG TABLET 60S pharmaceutical products to the U.S. Defense Logistics Agency (DLA) Troop Support Medical. The $4,605.80 Firm Fixed Price contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on August 13, 2024 with a completion date of August 14, 2024. This appears to be a delivery order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical,...
- This federal contract award is for the delivery of MULTAQ 400 MG TABLET 60S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $7,138.27 firm-fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on December 12, 2023. The contract has an ultimate completion date of December 13, 2023 and is not designated as a set-aside. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery...
- This federal contract award is for the delivery of MULTAQ 400 MG TABLET 60S medical supplies to the U.S. government. The contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the Department of Defense (DoD), to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract has a ceiling value of $8,687.77 and a period of performance through January 30, 2024. This is a delivery order contract with a firm fixed price pricing type. The...
- This federal contract award is for the delivery of MULTAQ 400 MG TABLET 60S medical supplies to the Defense Logistics Agency (DLA), a key agency within the U.S. Department of Defense. The $38,782.61 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of November 4, 2022 and was not set aside for any specific business type, indicating open competition....
- This federal contract award, valued at $1,576.84, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of MULTAQ 400 MG TABLET 60S, a pharmaceutical product, with a completion date of February 21, 2025. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November...
- SPE2DB20D1109Indefinite Delivery Contract
- SPE2DB20D1109-SPE2DB24FN38SDelivery Order
This federal contract award is for the delivery of MULTAQ 400 MG TABLET 60S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a for-profit pharmaceutical distribution company, on January 8, 2024. The contract has a ceiling value of $3,041.01 and a completion date of January 9, 2024. This contract is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through December 2025. The contract does not have a set-aside designation, indicating it was awarded through full and open competition. Amerisourcebergen is a key supplier of pharmaceutical products and medical supplies to various federal agencies, including the Department of Defense and Department of Veterans Affairs, supporting their healthcare programs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.0k | 1/8/24 |